Clinical Trials in Salt Lake City

Showing 1101-1120 of 16,694 trials

ETNA-MS Device Validation Study

NCT06256731

The overarching goal of this research protocol is to validate the effectiveness of Innodem's ETNA-MS device in informing clinicians on the disability status of Multiple Sclerosis (MS) patients. Effectiveness of the device will be assessed by the level of agreement between the EDSS estimated by the device and the actual scores measured by the neurologist in-person assessments.

Multiple Sclerosis

Innodem Neurosciences60 participantsStarted Dec 2023

Phoenix, Arizona, United States • Farmington Hills, Michigan, United States • Owosso, Michigan, United States +2 more locations

COMPLETEDNA< 1 mile

Checklist to Prevent MRSA Surgical Site Infections

NCT02216227

The goals of this project are 1) to assess the effectiveness and cost-effectiveness of the checklist to prevent MRSA SSIs among Veterans undergoing TJA or cardiac surgery, and 2) to assess barriers and facilitators to checklist implementation. Hypotheses: 1. The SSI checklist will be effective at reducing MRSA SSIs among total joint arthroplasty and cardiac surgery patients. 2. Implementation of the checklist will be associated with an overall reduction in SSIs caused by all pathogens. 3. The SSI Checklist will be cost-saving since it will prevent many expensive SSIs. 4. Preoperative MRSA testing will be a modifiable barrier to implementing the SSI checklist.

Surgical Site Infection

VA Office of Research and Development23,005 participantsStarted Apr 2014

Miami, Florida, United States • Iowa City, Iowa, United States • Baltimore, Maryland, United States +8 more locations

ETNA-MS Device Validation Study

Checklist to Prevent MRSA Surgical Site Infections

Find Trials by Condition in Salt Lake City

Dose-Ranging Study of the Efficacy and Safety of TAK-101 for Prevention of Gluten-Specific T Cell Activation in Participants With Celiac Disease on a Gluten-Free Diet

A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome

PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network Study

A Study of Elafibranor in Adults With Primary Biliary Cholangitis and Inadequate Response or Intolerance to Ursodeoxycholic Acid.

An Observational Study of Individuals With Isolated Dystonia

Effectiveness of the EMPOWER™ Modular Pacing System and EMBLEM™ Subcutaneous ICD to Communicate Antitachycardia Pacing

Open-label Extension Study of Brazikumab in Crohn's Disease

Efficacy and Safety of Iptacopan (LNP023) in Adult Patients With Atypical Hemolytic Uremic Syndrome Naive to Complement Inhibitor Therapy

AB-3028, a Programmable Circuit T Cell Therapy in Patients With Castration Resistant Prostate Cancer (CRPC)

Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Giant Cell Arteritis (GCA)

A Clinical Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) to Treat Newly-diagnosed Metastatic Non-small Cell Lung Cancer (MK-3475A-F84)

A Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of BCX17725

Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer

Development of Digital Biomarkers in Multiple Sclerosis: Validation Study 2

Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

Astroscape: A Study of Radiprodil on Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms in Patients With TSC or FCD Type II